Mira Pharmaceuticals (MIRA) Total Liabilities (2022 - 2025)

Mira Pharmaceuticals has disclosed Total Liabilities across 4 years of filings, most recently posting $702068.0 for Q4 2025.

• Total Liabilities for Q4 2025 came in at $702068.0, down 2.94% year-over-year; the trailing twelve-month figure through Dec 2025 was $702068.0 (down 2.94% YoY), and the FY2025 annual result was $702068.0, down 2.94% from the prior year.
• Total Liabilities came in at $702068.0 for Q4 2025 at Mira Pharmaceuticals, up from $83926.0 in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $2.6 million in Q2 2023 to a low of -$2.2 million in Q2 2024.
• The 4-year median for Total Liabilities is $652006.0 (2024), against an average of $464624.1.
• Across the five-year window, Total Liabilities jumped 381.76% in 2023 and tumbled 184.42% in 2024, its largest moves.
• Mira Pharmaceuticals' Total Liabilities stood at $1.5 million in 2022, then slumped by 61.62% to $558097.0 in 2023, then advanced by 29.61% to $723349.0 in 2024, then declined by 2.94% to $702068.0 in 2025.
• The last three Total Liabilities figures came in at $702068.0 (Q4 2025), $83926.0 (Q3 2025), and $298459.0 (Q2 2025), per Business Quant data.